AGILE THERAPEUTICS INC 8-K/A SEC Filings

Information in this exhibit identified by [***] is confidential and has been excluded pursuant to Item 601(b)(10(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant customarily a...

Information in this exhibit identified by [***] is confidential and has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information the registrant customarily and a...

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of August 16, 2023, by and between AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and Scott Coiante (the “Executive”), collectively referred to as the “pa...

At the Annual Meeting of Stockholders of Agile Therapeutics, Inc. (the “Company”) held on June 8, 2023 (the “Annual Meeting”), the Company’s stockholders approved the adoption of the Agile Therapeutics, Inc. 2023 Equity Incentive Plan (t...